AzTrials
AzTrials

Pilonidal SinusNCT05356208

Long-term Outcome After Cleft-lift for Pilonidal Sinus Disease

An observational study of Pilonidal Sinus, run by Nordsjaellands Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Single-center cohort study of 10-year risk of treatment failure after cleft-lift under tumescent local analgesia for pilonidal sinus disease Read more about this study

Who is it for?
Ages 14 to 99 years
Conditions the study is for
Pilonidal Sinus
How many people
224 participants
Where
1 siteDenmark
Study dates
1 Aug 2007to 31 May 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 99 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with moderate to complex pilonidal sinus disease referred to a secondary and tertiary care hospital. Patients with history of surgery for pilonidal sinus disease are included in the cohort.

Who may be able to join

  • Undergoing pit-pick at Nordsjællands Hospital during the study period

Who cannot join

  • Non-Danish residents
  • Patients planned for general anesthesia were excluded

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Nordsjaellands Hospital

    Hillerød, 3400

Other trials in Denmark

About this study

Official title: Long-term Outcome After Bascom's Cleft-lift Procedure Under Tumescent Local Analgesia for Pilonidal Sinus Disease: a Cohort Study

Single-center cohort study of 10-year risk of treatment failure after cleft-lift under tumescent local analgesia for pilonidal sinus disease

Read the detailed description

The standard treatment at Nordsjællands Hospital in Hillerød (NOH) has since 2007 been Bascom's pit-pick procedure (PP) for simple pilonidal sinus disease (PSD), while Bascom's cleft-lift procedure (CL)has been performed in complicated cases not suitable for PP operation, recurrences following previous excisions, including PP, and unhealed midline wounds.

CL has mainly been performed under tumescent local analgesia (TLA) in a day-surgery setting. TLA is well tolerated with high patient satisfaction and acceptable short-term outcomes. TLA provides a potentially higher cost-effectiveness not requiring presence of an anesthesiologist, shorter duration of the complete procedure and elimination of the risks and discomforts associated with general anesthetics.

The study is based on data of patients in a local pilonidal database. The patients in the database have all undergone surgery for pilonidal sinus disease at NOH during the period of 2007 to 2014. Data in the database has been collected prospectively up to one year following surgery and subsequently supplemented with data collected by questionnaire and telephone interviews for the period from one year follow-up and until the date of long-term follow-up. Study data were collected and managed using REDCap electronic data capture tools hosted at NOH.

Patients receive a REDCap survey per e-mail to a personal digital mailbox or are asked to participate in a telephone interview to fill out a standardized questionnaire. Patients without a personal digital mailbox receive the questionnaire by regular mail. The survey is sent out twice with a four-week interval. Only patients who do not fill out the questionnaire the first time, receive the survey a second time as a reminder. Telephone interviews are only conducted, if patients do not reply to the questionnaire received digitally or as a physical copy. The questionnaire includes questions regarding demographic characteristics, lifestyle, complications, recurrence and new interventions, pain, and cosmetic satisfaction. Medical records are reviewed to verify answers from the questionnaire if consent by the patient is given through the survey or during the telephone interview. Patients experiencing symptoms of recurrence, are offered an assessment at the hospital.

The procedure has been described previously and performed with minor modifications of the original description by John Bascom. All procedures were performed in a day-surgical setting. With the patient in the prone position, the natal cleft was opened and exposed by retraction with elastic bandage tape before the sterile surgical draping was applied. The resection area and a flap on the less affected side were outlined with the intention of 2-3 cm lateralization of the wound. A hockey incision was outlined in the distal part of the excision to achieve lateralization at the distal end of the wound. Subcutaneous TLA with a modified Klein's solution containing mepivacaine 0.8 mg/mL, adrenaline 1 µg/mL, and sodium bicarbonate 42 µg/mL in isotonic saline water was infused through a 2-inch 21-gauge needle under a pressure of approximately 300 mm hg using a pressure infusion bag. If fibrous tissue affected the subcutaneous tissue, the solution was infiltrated by a 20-ml syringe. In case of pain during surgery, a supplementary tumescent solution was administered. If acceptable analgesia could not be obtained, intravenous sedation or analgesia was administrated at the patient's request.

A flap with a thickness of approximately 7 mm was mobilized to the marked outer line to ensure tension-free tissue coverage of the excision. All primary pits in the midline were excised en-bloc, and all hair and granulation tissue in the subcutis was removed with a surgical swap or by curettage, saving as much fibrotic tissue as possible to provide padding. The retraction tape was released, and the surgical wound was closed with absorbable monofilament multilayer sutures subcutaneously with the intention of reducing any dead space in the subcutis before intracutaneous closure with polypropylene or monofilament short-term absorbable suture. A 10-French drain with no vacuum or silicon ribbon drains was placed under the flap. The wound was reinforced with strips and covered by a hydrofiber bandage. All patients received one dose of cefuroxime 1.5 g and metronidazole 1.0 g intravenously preoperatively, and cephalexin 500 mg and metronidazole 500 mg orally three times daily for three days as prophylaxis.

Risk of recurrence is analyzed using competing risk analysis as well as univariate and multivariate Cox regression analyses including the following risk factors: sex, age, smoking, BMI, relevant co-morbidities, diabetes mellitus, acne, hidradenitis, previous interventions, preoperative abscess, number of primary and secondary pits, number of lateral incisions and postoperative complications. Time to complete wound healing is analyzed by Kaplan-Meier plots. Remaining outcomes are analyzed as categorical variables using descriptive data analyses.

Conditions
Pilonidal Sinus
Keywords
Cleft-lift, Tumescent local analgesia
Medical subject headings
Pilonidal Sinus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment failure assessed by clinical assessment or by questionnaire

    Incomplete wound healing or recurrence after complete wound healing

    Measured: 10 years

Secondary outcomes (2)
  1. Chronic pain related to cicatrix

    Numerical rate scale pain score (0-10). 0 being no pain and 10 being the the worst

    Measured: 10 years

  2. Cosmetic appearance of the cicatrix

    Numerical rate scale score (1-5). 1 being worst, 5 the better

    Measured: 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2022
  2. Study start1 Aug 2007
  3. Primary completion31 May 2021
  4. Study completion31 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
224 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05356208
Sponsor's protocol ID
PSD - cleft-lift
Status last verified
Apr 2022
First submitted
26 Apr 2022
Last updated
29 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: fter de-identification, individual participant data will be made available to investigators who provide a methodologically sound proposal for meta-analyses.

Publications

  • Bertelsen CA. Cleft-lift operation for pilonidal sinuses under tumescent local anesthesia: a prospective cohort study of peri- and postoperative pain. Dis Colon Rectum. 2011 Jul;54(7):895-900. doi: 10.1007/DCR.0b013e31820ee852.

    PubMed 21654258
  • Svarre KJ, Serup CM, Kanstrup CTB, Kleif J, Bertelsen CA. Long-term outcome after Bascom's cleft-lift procedure under tumescent local analgesia for pilonidal sinus disease: a cohort study. Colorectal Dis. 2023 Apr;25(4):707-716. doi: 10.1111/codi.16420. Epub 2022 Nov 28.

    PubMed 36401803

Questions about this trial

What is this clinical trial studying?

An observational study of Pilonidal Sinus, run by Nordsjaellands Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment failure assessed by clinical assessment or by questionnaire (time frame: 10 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05356208, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in